PlainPharmaWatch

CMS Open Payments · Program Year 2024

Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. reported $6,082,240.03 in payments to 9,526 physicians and teaching hospitals across 9,559 transactions.

See the rankings → How this is sourced
$6.1M
Total payments
9,559
Transactions
9,526
Recipients
+$351.8K
General Payments vs PY2023

Tandem Diabetes Care, Inc. reported $6,082,240.03 in payments to 9,526 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #240 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $638.49 per recipient across 5 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Tandem Diabetes Care, Inc. pairs top-quartile payment volume with an unusually diversified payment pattern across a wide recipient base.

#240
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
5
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Tandem Diabetes Care, Inc.'s CMS-reported General Payments increased by $351.8K (+34.1%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: TANDEM DIABETES CARE, INC.PY2023: TANDEM DIABETES CARE, INC.PY2024: Tandem Diabetes Care, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$1.0MPY2024$1.4M
PY2023
$1,031,210.33
PY2024
$1,383,014.28

How Tandem Diabetes Care, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Tandem Diabetes Care, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$6,082,240 Top 12% higher than 88% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Tandem Diabetes Care, Inc.

Rank #240 of 1,925 companies in CMS Open Payments for 2024 belongs to Tandem Diabetes Care, Inc., which reported $6,082,240.03 across 9,559 transactions to 9,526 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $636.28 per transaction and $638.49 per recipient.

Of the 5 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $1.0M across 1,539 transactions, 16.8% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 5 types of general payments, Tandem Diabetes Care, Inc.'s largest category was "Compensation for Services Other Than Consulting" at $1.0M - 16.8% of the company's reported total.

How Tandem Diabetes Care, Inc. divides its payments

Top payment categories by total reported dollar volume

1. Compensation for Services…$1.0M2. Food and Beverage$257.7K3. Travel and Lodging$73.4K4. Consulting Fee$26.3K5. Space Rental or Facility …$2.1K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $1.0M 1,539
Food and Beverage $257.7K 7,889
Travel and Lodging $73.4K 59
Consulting Fee $26.3K 35
Space Rental or Facility Fees $2.1K 4

Recipient Concentration in General Payments

The five largest recipient relationships account for $246,645.00 (17.8%) of $1,383,014.28 in this company's General Payments records across 3,910 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Tandem Diabetes Care, Inc.

The five named recipients with the highest reported General Payments from this company

Hospital Of The Univ Of Penna$79.5KThe Toledo Hospital$48.5KDeaconess Medical Center$43.4KThe Childrens Hospital Of Ph…$38.9KOhsu Hospital And Clinics$36.3K
  1. 1

    Hospital Of The Univ Of Penna

    $79,500.00 across 1 reported transactions

  2. 2

    The Toledo Hospital

    $48,550.00 across 42 reported transactions

  3. 3

    Deaconess Medical Center

    $43,400.00 across 69 reported transactions

  4. 4

    The Childrens Hospital Of Philadelp

    $38,850.00 across 41 reported transactions

  5. 5

    Ohsu Hospital And Clinics

    $36,345.00 across 36 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $636.28. Average per recipient: $638.49.

Total Amount

$6,082,240.03

Avg per Transaction

$636.28

Avg per Recipient

$638.49

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Tandem Diabetes Care, Inc. Share

0.0%

#240 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Tandem Diabetes Care, Inc.

Cook Incorporated

$6.0M 985 recipients

Teleflex LLC

$6.0M 17,647 recipients

Roche Products Limited

$6.1M 124 recipients

Agios Pharmaceuticals, Inc.

$6.1M 3,134 recipients

Sobi, Inc

$6.1M 16,390 recipients

Coloplast Corp

$6.0M 19,137 recipients

Frequently Asked Questions

How much did Tandem Diabetes Care, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $6,082,240.03 from Tandem Diabetes Care, Inc. to physicians and hospitals across 9,559 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Tandem Diabetes Care, Inc.? ▾
Tandem Diabetes Care, Inc. made payments to 9,526 physicians and teaching hospitals in 2024. The average payment per recipient was $638.49.
What types of payments did Tandem Diabetes Care, Inc. make? ▾
5 categories of general payment make up Tandem Diabetes Care, Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Compensation for Services Other Than Consulting" at $1.0M, representing 16.8% of the company's reported total.
How does Tandem Diabetes Care, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Tandem Diabetes Care, Inc. sits at #240 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Tandem Diabetes Care, Inc.? ▾
In 2024, Tandem Diabetes Care, Inc. averaged $636.28 per transaction across 9,559 transactions to 9,526 recipients.
Where does the payment data for Tandem Diabetes Care, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Tandem Diabetes Care, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.